LYMPHANGIOLEIOMYOMATOSIS

This adverse event was reported 109 times

These drugs are most commonly taken by patients reporting LYMPHANGIOLEIOMYOMATOSIS:

# Drug Count
0 EVEROLIMUS 19
1 LAMOTRIGINE 19
2 OMEPRAZOLE MAGNESIUM 17
3 OMEPRAZOLE 16
4 CARBOPLATIN 15
5 CISPLATIN 15
6 GEMCITABINE HYDROCHLORIDE 15
7 NIRAPARIB 15
8 TRABECTEDIN 15
9 DOXORUBICIN 13
See all common drugs associated with LYMPHANGIOLEIOMYOMATOSIS

LYMPHANGIOLEIOMYOMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRABECTEDIN 15 0.0064
1 EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL 1 0.0042
2 PHENOBARBITAL 12 0.0008
3 CLOBAZAM 12 0.0007
4 NIRAPARIB 15 0.0007
5 CLOMIPHENE CITRATE 1 0.0007
6 DESFLURANE 1 0.0006
7 PHENYTOIN 11 0.0005
8 DEFEROXAMINE MESYLATE 1 0.0005
9 SULINDAC 1 0.0004
See all drugs enriched for association with LYMPHANGIOLEIOMYOMATOSIS

LYMPHANGIOLEIOMYOMATOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Erythroid Maturation Agent [EPC] 1 0.0004
1 Lipid-based Polyene Antifungal [EPC] 2 0.0002
2 Glinide [EPC] 1 0.0001
3 Mood Stabilizer [EPC] 20 0.0001
4 Anti-epileptic Agent [EPC] 20 0.0001
5 Alkylating Drug [EPC] 15 0.0001
6 Platinum-based Drug [EPC] 15 0.0001
7 Aromatase Inhibitor [EPC] 6 0.0001
8 Polyene Antifungal [EPC] 2 0.0000
9 Microtubule Inhibitor [EPC] 8 0.0000
See all drug classes enriched for association with LYMPHANGIOLEIOMYOMATOSIS